Galmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for Aramchol
09 Nov, 2020 – Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) and MyBiotics Pharma Ltd. announced they have entered into a research and development collaboration agreement to identify and [...]
